Somatostatin and the gastrointestinal tract.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Scandinavian Journal of Gastroenterology, Supplement

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/003655298750026642PMID 9867121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas

  1995cited by this paper
• Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis

  1995cited by this paper
• Sclerotherapy with or without octreotide for acute variceal bleeding.

  1995cited by this paper
• The relative effectiveness of somatostatin and octreotide therapy in pancreatic disease

  1995cited by this paper
• The Use of a Long-Acting Somatostatin Analogue (Octreotide) for Prophylaxis of Acute Pancreatitis after Endoscopic Sphincterotomy

  1994cited by this paper
• Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy.

  1994cited by this paper
• Efficacy of octreotide in the prevention of complications of elective pancreatic surgery

  1994cited by this paper
• Efficacy of octreotide in the prevention of complications of elective pancreatic surgery

  1994cited by this paper
• Octreotide infusion or emergency sclerotherapy for variceal haemorrhage.

  1993cited by this paper
• Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial

  1993cited by this paper
• A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.

  1993cited by this paper
• Short report: octreotide in the treatment of external pancreatic fistulas

  1993cited by this paper
• Octreotide.

  1992cited by this paper
• Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

  1992cited by this paper
• A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding.

  1992cited by this paper
• Somatostatin and octreotide in gastroenterology

  1991cited by this paper
• The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography.

  1991cited by this paper
• Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis.

  1991cited by this paper
• Comparison of somatostatin and vasopressin in bleeding esophageal varices.

  1990cited by this paper
• Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial.

  1989cited by this paper
• Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding.

  1989cited by this paper
• Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: a prospective, randomized, controlled trial.

  1989cited by this paper
• A multicenter, randomized, double‐blind trial of somatostatin in the management of acute hemorrhage from esophageal varices

  1989cited by this paper
• Physiological significance of gastrointestinal somatostatin.

  1988cited by this paper
• Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage.

  1985cited by this paper
• Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro.

  1968cited by this paper

• Pasireotide Exerts Anti‐Inflammatory Effects in the Endothelium

  2025cites this paper
• Enteroendocrine cell differentiation: implications for human disease.

  2025cites this paper
• Clinical trial: The effectiveness of long-acting somatostatin analogue for output reduction of high-output intestinal fistula or small bowel enterostomy. A randomised controlled trial.

  2024cites this paper
• The Silent Spill: A Case Report on Navigating the Challenges of a Chyle Leak

  2024cites this paper
• Emerging pharmacological targets for alcohol use disorder.

  2024cites this paper
• Effect of postoperative utilization of somatostatin on clinical outcome after definitive surgery for duodenal fistula

  2023cites this paper
• GPR84 in physiology—Many functions in many tissues

  2023cites this paper
• Identification of SSTR5 Gene Polymorphisms and Their Association With Growth Traits in Hulun Buir Sheep

  2022cites this paper
• MANAGEMENT OF CHYLE LEAK FOLLOWING HEAD AND NECK SURGERY: REVIEW OF CURRENT TREATMENT STRATEGIES AND ALGORITHMIC APPROACH TO THE TREATMENT

  2022cites this paper
• Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome

  2022cites this paper
• Role of octreotide in small bowel bleeding

  2022cites this paper
• Knock-in Mouse Models for Studying Somatostatin and Cholecystokinin Expressing Cells.

  2022cites this paper
• Identification of Somatostatin Receptor Subtype 1 (SSTR1) Gene Polymorphism and Their Association with Growth Traits in Hulun Buir Sheep

  2021cites this paper
• Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study.

  2021cites this paper
• Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity

  2020influential citation
• The Predicament of Gastrointestinal Bleeding in Patients with a Continuous Flow Left Ventricular Assist Device: Pathophysiology, Evaluation and Management.

  2019cites this paper
• Lanreotide in the management of small bowel angioectasias: seven-year data from a tertiary centre

  2017cites this paper
• Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer

  2017cites this paper
• Gastrointestinal Angiodysplasia: Diagnosis and Management.

  2017cites this paper
• Character and laxative activity of polysaccharides isolated from Dendrobium officinale

  2017cites this paper
• Tolerability and Biological Effects of Long-Acting Octreotide in Patients With Continuous Flow Left Ventricular Assist Devices

  2017cites this paper
• Cysteamine: a human health dietary additive with potential to improve livestock growth rate and efficiency

  2016cites this paper
• Somatostatin expression in the pancreatic cells of smoking and non-smoking chronic pancreatitis patients with or without diabetes.

  2016cites this paper
• Somatostatin Analogs in the Medical Management of Occult Bleeding of the Lower Digestive Tract

  2015cites this paper
• Possibilities and Limits of Medical Treatment

  2015cites this paper
• Cysteamine hydrochloride increases bodyweight and wool fibre length, improves feed conversion ratio and reduces methane yield in sheep

  2014cites this paper
• Somatostatin analogues for treatment of enterocutaneous fistula

  2013cites this paper
• Systematic review and meta-analysis of the role of somatostatin and its analogues in the treatment of enterocutaneous fistula

  2011cites this paper
• Effects of octreotide on jejunal hypersensitivity triggered by Cryptosporidium parvum intestinal infection in an immunocompetent suckling rat model

  2011cites this paper
• The influence of the different morphological changes on gastric mucosa on somatostatin cell number in antrum mucosa and serum somatostatin.

  2011cites this paper
• Molecular characterization and polymorphisms of the caprine Somatostatin (SST) and SST Receptor 1 (SSTR1) genes that are linked with growth traits

  2011cites this paper
• Gene Expression Profiles of Colonic Mucosa in Healthy Young Adult and Senior Dogs

  2010cites this paper
• Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.

  2009cites this paper
• Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy of Lanreotide 30 mg PR in the Treatment of Pancreatic and Enterocutaneous Fistulae

  2009cites this paper
• Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.

  2008cites this paper
• Effect of long‐term treatment with octreotide on rectal sensitivity in patients with non‐constipated irritable bowel syndrome

  2007cites this paper
• Management of intestinal involvement in systemic sclerosis.

  2007cites this paper
• Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones

  2007cites this paper
• Spontaneous hypersensitivity in mesenteric afferent nerves of mice deficient in the sst2 subtype of somatostatin receptor

  2007cites this paper
• An immunohistochemical study of endocrine cells in the stomach of hypertensive rats.

  2007cites this paper
• Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon

  2006cites this paper
• Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells

  2006cites this paper
• Capítulo 106 – Hormonas gastrointestinales

  2006cites this paper
• CHAPTER 15 – Regulation of Gastrointestinal Normal Cell Growth

  2006cites this paper
• Pharmacological therapy of vascular malformations of the gastrointestinal tract.

  2006cites this paper
• The puzzle of somatostatin: action, receptors, analogues and therapy.

  2005cites this paper
• Cellular detection of sst2A receptors in human gastrointestinal tissue

  2004cites this paper
• LETTER: Octreotide for Gastrointestinal Bleeding of Obscure Origin in an Anticoagulated Patient

  2004cites this paper
• Effects of duodenogastric reflux on gastrin cells, somatostatin cells and serotonin cells in human antral gastric mucosa.

  2004cites this paper
• Pharmacologic management of obscure gastrointestinal bleeding

  2003cites this paper
• Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.

  2003cites this paper
• Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels.

  2003cites this paper
• Ultrastructural immunohistochemical localization of gastrin, somatostatin and serotonin in endocrine cells of human antral gastric mucosa.

  2003cites this paper
• Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation

  2003cites this paper
• Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues.

  2003cites this paper
• Are somatostatin analogues (octreotide and lanreotide) effective in promoting healing of enterocutaneous fistulas?

  2002cites this paper
• Octreotide for gastrointestinal bleeding of obscure origin in an anticoagulated patient.

  2002cites this paper
• The influence of somatostatin on bacterial translocation.

  2001cites this paper
• Modern management of cancer-related intestinal obstruction

  2001cites this paper
• Electron microscopic immunohistochemical investigation of chromogranin A in endocrine cells in human oxyntic gastric mucosa.

  2001cites this paper
• Light and electron microscopic immunohistochemical investigation on G and D cells in antral mucosa in Helicobacter pylori-related gastritis.

  2001cites this paper
• Modern management of cancer-related intestinal obstruction

  2000cites this paper
• Hormones and the gut.

  2000cites this paper
• Somatostatin receptor ligands and their use in the treatment of endocrine disorders.

  1999cites this paper